Results 91 to 100 of about 17,628 (210)

Integrative Multi‐Omics and Experimental Validation Define RELB as an Immune‐Related Prognostic Driver in Ovarian Cancer

open access: yesChemical Biology &Drug Design, Volume 108, Issue 4, October 2026.
Integrated multi‐omics identified key genes associated with the immune microenvironment in ovarian cancer, and functional assays validated the role of key genes in ovarian cancer. ABSTRACT Ovarian cancer (OC) is one of the most aggressive gynecological malignancies worldwide.
Wenshu Leng, Xingyue Fan, Yichen Fang
wiley   +1 more source

The ability of whole-body SUVmax in F-18 FDG PET/CT to predict suboptimal cytoreduction during primary debulking surgery for advanced ovarian cancer

open access: yesJournal of Ovarian Research, 2019
Background The aim of this study was to (1) evaluate the ability of F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) parameters to predict suboptimal cytoreduction and (2) to create a risk model for predicting ...
Gun Oh. Chong   +7 more
doaj   +1 more source

First experience of durable cytoreduction in chronic lymphoid leukemia with (177)Lu-DOTATATE.

open access: yes, 2019
This is the first described case of effective and durable cytoreduction after PRRT with 177 Lu-DOTATATE in a 75-year-old female, with B cell chronic lymphoid leukemia, and well-differentiated metastatic neuroendocrine ...
Prior, J.O.   +13 more
core   +1 more source

Interval Debulking Surgery (IDS) in Advanced Ovarian Cancer – Immediate Surgical Outcomes and Optimal Cytoreduction Rate

open access: yes, 2020
Introduction: In Indian women, ovarian cancer is the fourth most common cancer, out of which epithelial ovarian cancers are the most common and present in advanced stage.
Mahalakshmi Pendurthi, Ratnesh, Anuvi
core   +1 more source

Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2014
Objective: This study aimed to identify features on preoperative computed tomography (CT) scans that are predictive of suboptimal primary cytoreduction and to evaluate the correlation between CT findings and intraoperative findings in advanced ovarian ...
Ha-Jeong Kim   +6 more
doaj   +1 more source

Personalised treatment of patients with advanced ovarian cancer: comparative analysis of surgical approaches

open access: yesJournal of Education, Health and Sport
The authors analysed the results of treatment of patients with advanced ovarian cancer depending on the surgical approach used and the results of NIRES application.
A. Rybin   +3 more
doaj   +1 more source

Complete elimination of hyperleukocytosis risk in AML through early high-quality disease remission

open access: yesFrontiers in Oncology
BackgroundAcute myeloid leukemia (AML) with hyperleukocytosis (HL) is a severe medical emergency associated with high mortality rates and poor prognosis. Prompt and urgent treatment is crucial to address this medical emergency.
Guoqing Lyu   +4 more
doaj   +1 more source

Paclitaxel as HIPEC-Drug after Surgical Cytoreduction for Ovarian Peritoneal Metastases: A Randomized Phase III Clinical Trial (HIPECOVA)

open access: yesCurrent Oncology
Multidisciplinary strategies have transformed the management of advanced ovarian cancer. We aimed to evaluate the effectiveness of paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) following surgical cytoreduction for ovarian peritoneal ...
Pedro Villarejo Campos   +8 more
doaj   +1 more source

Mediastinal Metastasis Isolated in Ovarian Cancer: A Systematic Review

open access: yesLife
Background: Isolated mediastinal metastases from ovarian carcinoma are considered exceptional. Since such metastases are considered advanced stage disease, systemic therapy is the indicated therapeutic approach; however, some articles report that ...
Victoria Psomiadou   +2 more
doaj   +1 more source

Positron Emission Tomography–Laparoscopy Based Method in the Prediction of Complete Cytoreduction in Platinum-Sensitive Recurrent Ovarian Cancer

open access: yes, 2015
Methods: We analysed 223 consecutive recurrent epithelial ovarian cancer patients. Inclusion criteria were absence of extra-abdominal disease and Eastern Cooperative Oncology Group Performance Status ≤2.
Costantini B.   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy